Shares of Max Healthcare Institute fell more than 6% in early trade on Friday, May 22, after the hospital operator reported its March quarter (Q4 FY26) earnings. As of 9:35 AM, the stock was trading sharply lower even though the company posted growth in revenue and profit on a year-on-year basis.
The company reported consolidated gross revenue of ₹2,664 crore for the fourth quarter, marking a 10.0% increase compared to the same period last year. Net revenue rose 9.0% to ₹2,541 crore from ₹2,326 crore in the year-ago quarter.
Reported operating EBITDA increased 8.0% year-on-year to ₹682 crore versus ₹632 crore in the corresponding quarter last year. However, operating EBITDA margin slipped 40 basis points to 26.8% from 27.2%, indicating some pressure on profitability despite higher revenues.
Profit after tax (PAT) came in at ₹387 crore, up 3.0% from ₹376 crore reported in the same quarter last year.
The company also reported an improvement in Average Revenue Per Occupied Bed (ARPOB), which increased to ₹77,900 from ₹77,100 on a year-on-year basis, reflecting better realisations across its hospital network.
Despite the steady operational growth, investors appeared cautious over margin compression, leading to selling pressure in the stock during morning trade.
Max Healthcare share price movement
As of 9:35 AM, Max Healthcare shares were trading near the day’s low after witnessing sharp intraday volatility.
- Today’s high: ₹1,068.25
- Today’s low: ₹1,011.30
- Opening price: ₹1,068.25
- Previous close: ₹1,091.10
- 52-week high: ₹1,314.30
- 52-week low: ₹903.00
- Live traded volume: 21.91 lakh shares
The sharp decline comes even as the broader healthcare sector remains in focus amid ongoing earnings announcements for the March quarter.